BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis C
Clinical trial NCT01623336 · UNKNOWN
Trial details
- NCT number
- NCT01623336
- Sponsor
- The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2016-08-01
- Enrollment
- 740
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.